– Dow Jones
UK Competition And Markets Authority Accuses Pfizer Of Illegal Pricing Of Its Epilepsy Drug
Pfizer Inc (NYSE: PFE) and Flynn Pharma Ltd have been accused by the U.K.'s competition watchdog of
Related Posts
Credit Suisse Maintains Outperform on T-Mobile US, Lowers Price Target to $175
Credit Suisse analyst Douglas Mitchelson maintains T-Mobile US (NASDAQ:TMUS) with a Outperform and lowers the price target from $188 to $175.
Coinbase CEO Gives Apple’s Example As He Calls For Building The ‘Crypto App Store’
Coinbase Global Inc (NASDAQ: COIN) CEO Brian Armstrong, in a blog post on Tuesday, called for the building of the “crypto app store” similar to the one created by Apple Inc (NASDAQ: AAPL).
